[Vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic].
OBJECTIVE
The aim of this non-interventional, non-comparative, prospective, multicentric study was to evaluate use of vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic.


METHODS
Non-interventional, non-comparative, prospective, multicentric study.


METHODS
Department of obstetrics and gynecology, General Faculty Hospital Prague, 1st Faculty of Medicine, Charles University Prague.


METHODS
The cohort of 2134 new users of NuvaRing was followed for 6 months. Questionnaire was filled in by the physician (gynaecologist) three times during the study--before the start of NuvaRing use (baseline), after 3 months and after 6 months of the ring use.


RESULTS
The average age of women in study was 29.5 years, 68.2% was from 21 to 35 years old. Insertion and removal of the ring were evaluated as easy in 95% of women in the end of the study. Irregular bleeding was mentioned only in 19.7% of women during first 3 cycles and 7.8% during last 3 cycles, mostly (90%) as spotting. Menstrual bleeding was shorter in 62.8% of women in the end of the study compared with the baseline. Dysmenorea decreased by 34.9% and PMS by 28.8% in the last evaluated cycle compared with the baseline. No feeling or only exceptional feeling the of the ring in the vagina was reported in 87% of women and in 77.9% of their sexual partners during the last 3 cycles. The main two reasons why women like NuvaRing was no need to remember anything (57.5%) and easy use (34%). The main reasons why women dislike the ring were feeling of the ring in the vagina in 2.9%, disturbing of sexual intercourse in 2.4% and irregular bleeding in 2%. (90% answered, that they like NuvaRing.)


CONCLUSIONS
After six months of use 89% of women was satisfied or highly satisfied with the vaginal ring and 91% of the users was decided to recommend this contraception method to other women.
Fait
T
T
Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha. tfait@seznam.cz
D000328:Adult; D003274:Contraceptive Devices, Female / Q000009:adverse effects; D017135:Desogestrel / Q000009:adverse effects / Q000031:analogs & derivatives; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D017060:Patient Satisfaction; D055815:Young Adult
D004338:Drug Combinations; C516519:NuvaRing; D004997:Ethinyl Estradiol; D017135:Desogestrel